Roivant Sciences (ROIV) Interest Expenses (2020 - 2026)
Roivant Sciences (ROIV) posted Interest Expenses of $1.6 billion for Q1 2026, up 2419495.45% on a QoQ basis from $66000.0 in Q3 2025, and up 127.74% year-over-year from $701.2 million in Q1 2025.
Roivant Sciences (ROIV) Interest Expenses (2020 - 2026) Analysis & Trends
Roivant Sciences' Interest Expenses history runs 7 years deep, the most recent figure standing at $1.6 billion for Q1 2026.
- Quarterly Interest Expenses rose 127.74% year-over-year to $1.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 127.74% YoY) and the FY2026 annual result came in at $1.6 billion, up 127.74% from the prior year.
- Interest Expenses was $1.6 billion for Q1 2026 at Roivant Sciences, up from $66000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $1.6 billion in Q1 2026 and bottomed at $66000.0 in Q3 2025.
- A 5-year average of $171.3 million and a median of $15.6 million in 2022 frame the typical range for Interest Expenses.
- Peak annual rise in Interest Expenses reached 5965.38% in 2025, while the deepest fall reached 99.94% in 2025.
- Roivant Sciences' Interest Expenses stood at $19.4 million in 2022, then soared by 42.33% to $27.6 million in 2023, then jumped by 310.1% to $113.2 million in 2024, then sank by 99.94% to $66000.0 in 2025, then surged by 2419495.45% to $1.6 billion in 2026.
- Business Quant data shows ROIV's Interest Expenses at $1.6 billion in Q1 2026, $66000.0 in Q3 2025, and $184000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | 1.60 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.60 Bn |
| Mar 31, 2026 | 1.60 Bn |
| Sep 30, 2025 | 66,000.00 |
| Sep 30, 2025 | 66,000.00 |
| Jun 30, 2025 | 184,000.00 |
| Jun 30, 2025 | 184,000.00 |
| Mar 31, 2025 | 701.22 Mn |
| Mar 31, 2025 | 701.22 Mn |
| Dec 31, 2024 | 113.20 Mn |
| Dec 31, 2024 | 113.20 Mn |
| Sep 30, 2024 | 115.00 Mn |
| Sep 30, 2024 | 115.00 Mn |
| Jun 30, 2024 | 81.40 Mn |
| Jun 30, 2024 | 81.40 Mn |
| Mar 31, 2024 | 11.56 Mn |
| Mar 31, 2024 | 11.56 Mn |
| Dec 31, 2023 | 27.60 Mn |
| Dec 31, 2023 | 27.60 Mn |
| Sep 30, 2023 | 9.30 Mn |
| Sep 30, 2023 | 9.30 Mn |